![Neil McFarlane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 31/05/2026
Neil F.
McFarlane is President, Chief Executive Officer & Director at Zevra Therapeutics, Inc. since 2023.
Former roles include Chief Executive Officer at Adamas Pharmaceuticals LLC from 2019 to 2021, Independent Director at Collegium Pharmaceutical, Inc. from 2022 to 2024, Vice President & General Manager at UCB, Inc. from 2011 to 2016, and Chief Operating Officer at Travere Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate and graduate degrees from the University of Florida.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC. 0,51 % | 06/04/2026 | 304.282 ( 0,51 % ) | 4 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director Ejecutivo | 10/10/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Director/Miembro de la Junta | 28/07/2024 |
| ADAMAS PHARMACEUTICALS, INC. | Director Ejecutivo | 01/11/2021 |
| TRAVERE THERAPEUTICS, INC. | Director de Operaciones | 31/05/2019 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01/01/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
